-83% Off

Resof-L Tablet

Original price was: ₹25,781.25.Current price is: ₹4,500.00.

The Resof-L Tablet serves as a combined antiviral medication. It gets used to handle hepatitis C. The main thing it does is go after the virus itself.

Product Details

Salt/Formula: Ledipasvir (90mg) + Sofosbuvir (400mg)

Manufacturer: Dr Reddy's Laboratories Ltd

Dosage: 90+400mg

Doctor's Prescription Required for this Product.

Out of stock

Benefits

Hepatitis C turns out to be an infection that affects the liver. It gets caused by something called the hepatitis C virus, or HCV for short.

When the infection hangs around for a really long time, that leads to chronic hepatitis C.

The Resof-L Tablet helps lower the amount of virus present. It does this by stopping the virus from spreading further inside the body.

This treatment controls the infection pretty well. It also makes recovery happen a bit faster overall.

You need to take the Resof-L Tablet exactly the way your doctor prescribes it.

How to use

Take this medicine exactly in the dose and duration prescribed by your doctor. Do not skip doses or stop the treatment without medical advice.

Specification

Take this medicine exactly in the dose and duration prescribed by your doctor. Do not skip doses or stop the treatment without medical advice.

Side Effects

Most side effects end up being pretty mild. They often fade away once your body starts adjusting to the treatment.

You need to check with your doctor.

Do that if side effects stick around or start bothering you.

Common side effects from Resof-L include tiredness.

Headache shows up too.

Description

The Resof-L Tablet puts together two antiviral medicines in one dose. Doctors prescribe it mainly for handling chronic hepatitis C infection. That means the HCV type that sticks around long term. It works by fighting off the virus step by step. In the end it helps clear the whole infection from the body.

Reviews

There are no reviews yet.

Be the first to review “Resof-L Tablet”

Your email address will not be published. Required fields are marked *